You are here

  • Home
  • Archive
  • Volume 60, Issue 1
  • Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

Citation Tools

Article menu
Download PDFPDF
Concise report
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mediwake R, Isenberg DA, Schellekens GA, et al
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis
Annals of the Rheumatic Diseases 2001;60:67-68.